These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 5502530)

  • 1. [Results obtained by high doses of cyclophosphamide in solid tumors].
    Bilge N; Aran M
    Turk Tip Cemiy Mecm; 1970 Feb; 36(2):116-27. PubMed ID: 5502530
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose mitoxantrone and cyclophosphamide without stem cell support in high-risk and advanced solid tumors: a phase I trial.
    Pérez-Gracia JL; Colomer R; Ruiz-Casado A; Arcediano A; Tornamira MV; Gómez-Martin C; Valentin V; Mendiola C; Cortés-Funes H; Hornedo J
    Bone Marrow Transplant; 2001 Jan; 27(2):117-23. PubMed ID: 11281378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.
    Young SD; Whissell M; Noble JC; Cano PO; Lopez PG; Germond CJ
    Clin Cancer Res; 2006 May; 12(10):3092-8. PubMed ID: 16707607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [First clinical experiences with ultrahigh single doses of cyclophosphamide].
    Schmitz G; Gross R
    Med Welt; 1967 Apr; 16():985-9. PubMed ID: 5585096
    [No Abstract]   [Full Text] [Related]  

  • 5. The pediatric preclinical testing program: description of models and early testing results.
    Houghton PJ; Morton CL; Tucker C; Payne D; Favours E; Cole C; Gorlick R; Kolb EA; Zhang W; Lock R; Carol H; Tajbakhsh M; Reynolds CP; Maris JM; Courtright J; Keir ST; Friedman HS; Stopford C; Zeidner J; Wu J; Liu T; Billups CA; Khan J; Ansher S; Zhang J; Smith MA
    Pediatr Blood Cancer; 2007 Dec; 49(7):928-40. PubMed ID: 17066459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Limits and possibilities of cytostatic therapy with massive doses of cyclophosphamide].
    Chiarelli G; Garutti GP; Rambaldi P
    Arcisp S Anna Ferrara; 1967; 20(3):385-400. PubMed ID: 5606860
    [No Abstract]   [Full Text] [Related]  

  • 7. [Compatibility and action of very high dosage of endoxuan in the treatment of tumors].
    Martini H; Scheef W; Knecht B
    Med Welt; 1967 Jul; 26():1573-8. PubMed ID: 5616188
    [No Abstract]   [Full Text] [Related]  

  • 8. [Association of radio- and chemotherapy: observations and results in 126 patients with tumors].
    Beyer W; Neumeister K; Pfeiffer J; Luschnitz E; Schmutzler W
    Radiobiol Radiother (Berl); 1970; 11(4):369-73. PubMed ID: 5508944
    [No Abstract]   [Full Text] [Related]  

  • 9. Accuracy, feasibility, and clinical impact of prospective Bayesian pharmacokinetically guided dosing of cyclophosphamide, thiotepa, and carboplatin in high-dose chemotherapy.
    de Jonge ME; Huitema AD; Tukker AC; van Dam SM; Rodenhuis S; Beijnen JH
    Clin Cancer Res; 2005 Jan; 11(1):273-83. PubMed ID: 15671556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cyclophosphamide treatments against primary mammary tumors in C3H/He mice.
    Costanza ME; Vaage J
    J Natl Cancer Inst; 1983 Mar; 70(3):511-6. PubMed ID: 6572739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttransplant administration of cyclophosphamide and donor lymphocyte infusion induces potent antitumor immunity to solid tumor.
    Eto M; Kamiryo Y; Takeuchi A; Harano M; Tatsugami K; Harada M; Kiyoshima K; Hamaguchi M; Teshima T; Tsuneyoshi M; Yoshikai Y; Naito S
    Clin Cancer Res; 2008 May; 14(9):2833-40. PubMed ID: 18451251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results with cyclophosphamide therapy in single and massive dosage].
    Helbig W; Mühl H
    Z Gesamte Inn Med; 1967 Dec; 22(24):811-4. PubMed ID: 5585478
    [No Abstract]   [Full Text] [Related]  

  • 13. Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
    Leggas M; Stewart CF; Woo MH; Fouladi M; Cheshire PJ; Peterson JK; Friedman HS; Billups C; Houghton PJ
    Clin Cancer Res; 2002 Sep; 8(9):3000-7. PubMed ID: 12231547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in growth rate of an experimental solid tumor following increasing doses of cyclophosphamide.
    Looney WB; Ritenour ER; Hopkins HA
    Cancer Res; 1980 Jul; 40(7):2179-83. PubMed ID: 7388785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiences with the endoxan intensive therapy of malignant tumors].
    Gebhardt KH; Becher R
    Med Welt; 1966 Apr; 17():973-6. PubMed ID: 5985776
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors.
    Ziegler DS; Cohn RJ; McCowage G; Alvaro F; Oswald C; Mrongovius R; White L;
    Neuro Oncol; 2006 Jan; 8(1):53-9. PubMed ID: 16443948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial.
    Stiff PJ; Bayer R; Tan S; Camarda M; Sosman J; Peace D; Kinch L; Rad N; Loutfi S
    Clin Cancer Res; 1995 Dec; 1(12):1495-502. PubMed ID: 9815949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term postoperative treatment with cyclophosphamide].
    Wilmanns H
    Laval Med; 1968 Oct; 39(8):728-33. PubMed ID: 5748238
    [No Abstract]   [Full Text] [Related]  

  • 19. [Platelet concentrate transfusion during polychemotherapy of children with solid tumors].
    Koposov PV; KovalevI VI; Strykov VA; Kovalev LV; Loseva MS; Starostina AIu; Prostomolotov OA; Zakharov MV
    Vopr Onkol; 2002; 48(3):365-8. PubMed ID: 12455364
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems of clinical cancerology: cytostatic shock with cyclophosphamide].
    Cittadini G
    Minerva Med; 1966 May; 57(39):1715-23. PubMed ID: 5939618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.